Clinical Trial Update: Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is comparing trastuzumab rezetecan with radiotherapy versus trastuzumab rezetecan alone in patients with HER2-positive advanced brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Trastuzumab Rezetecan

Snippet

Sponsor: Henan Cancer Hospital | Conditions: HER2-positive Advanced Breast Cancer, Brain Metastases | Phase 2 | Status: RECRUITING